Evidence map›Paper›PMID 37154747›Full record

ArticlemBio2023

Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene Expression.

Lilian Göttig, Christina Weiß, Miona Stubbe, Lisa Hanrieder, Samuel Hofmann, Alessandro Grodziecki, Daniela Stadler, Arnaud Carpentier, Ulrike Protzer, Sabrina Schreiner

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. The adenovirus DNA-binding protein DBP.Journal of virology · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lilian Göttig *Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Christina Weiß *Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Miona StubbeInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Lisa HanriederInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Samuel HofmannInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Alessandro GrodzieckiInstitute of Virology, Hannover Medical School, Hannover, Germany.
Daniela StadlerInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Arnaud CarpentierInstitute of Experimental Virology, Twincore, Hannover, Germany.
Ulrike ProtzerInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
Sabrina SchreinerInstitute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0002-5744-7159
Technical University of Munich · DEMedizinische Hochschule Hannover · DEHelmholtz Zentrum München · DECenter for Experimental and Clinical Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apobec3A is involved in the antiviral host defense, targeting nuclear DNA, introducing point mutations, and thereby activating DNA damage response (DDR). Here, we found a significant upregulation of Apobec3A during HAdV infection, including Apobec3A protein stabilization mediated by the viral proteins E1B-55K and E4orf6, which subsequently limited HAdV replication and most likely involved a deaminase-dependent mechanism. The transient silencing of Apobec3A enhanced adenoviral replication. HAdV triggered Apobec3A dimer formation and enhanced activity to repress the virus. Apobec3A decreased E2A SUMOylation and interfered with viral replication centers. A comparative sequence analysis revealed that HAdV types A, C, and F may have evolved a strategy to escape Apobec3A-mediated deamination via reduced frequencies of TC dinucleotides within the viral genome. Although viral components induce major changes within infected cells to support lytic life cycles, our findings demonstrate that host Apobec3A-mediated restriction limits virus replication, albeit that HAdV may have evolved to escape this restriction. This allows for novel insights into the HAdV/host-cell interplay, which broaden the current view of how a host cell can limit HAdV infection.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanCOVID-19AdenoviridaeAntiviral AgentsCOVID-19 VaccinesCytidine DeaminaseDeaminationGene ExpressionHumansProteinsVirus ReplicationAntiviral AgentsAPOBEC3A protein, humanCOVID-19 VaccinesCytidine DeaminaseProteinsA3AadenovirusApobecdeaminationHAdVSUMOSUMOylationvirus host interaction

Identifiers

PMID37154747
PMCPMC10294656
OpenAlexW4375859844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.